IMC Chicago
GMAB icon

IMC Chicago’s Genmab GMAB Stock Holding History

IMC Chicago’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.97M Buy
+71,596
New +$1.9M ﹤0.01% 3053
2026
Q1 		– Sell
-27,537
Closed -$825K – 5819
2025
Q4 		$848K Buy
27,537
+15,422
+127% +$481K ﹤0.01% 3117
2025
Q3 		$372K Buy
+12,115
New +$295K ﹤0.01% 3333

Other funds holding GMAB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
LWAM
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 35.19% 1-Year Est. Return

IMC Chicago's GMAB Position: Q2 2026 in Review

IMC Chicago opened a new position in Genmab (GMAB) in Q2 2026: 71,596 shares worth $1.97M. The stake represents ﹤0.01% of the portfolio and ranks #3053 among its holdings. This is a return to the name: IMC Chicago previously reported a position in GMAB as recently as Q4 2025.

IMC Chicago first reported a position in GMAB in Q3 2025 and has held it in 3 quarters since. 135 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • IMC Chicago held 71,596 shares of Genmab worth $1.97M as of Q2 2026.
  • Genmab was a new IMC Chicago position in Q2 2026.
  • Genmab made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #3053 holding.
  • IMC Chicago first reported a position in Genmab in Q3 2025 and has held it in 3 quarters since.
  • 135 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.